Skip to main content

ADVERTISEMENT

screening guidelines

Interview
01/11/2019
JCP Editors
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
...
01/11/2019
Journal of Clinical Pathways
Research in Review
07/03/2017
JCP Editors
Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...
Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...
...
07/03/2017
Journal of Clinical Pathways
Research in Review
05/23/2017
JCP Editors
A diagnostic magnetic resonance imaging (MRI) scan followed by an MRI-guided biopsy strategy is more cost-effective than an invasive transrectal ultrasound for detecting prostate cancer, according to research...
A diagnostic magnetic resonance imaging (MRI) scan followed by an MRI-guided biopsy strategy is more cost-effective than an invasive transrectal ultrasound for detecting prostate cancer, according to research...
A...
05/23/2017
Journal of Clinical Pathways
Research in Review
05/19/2017
JCP Editors
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
05/16/2017
JCP Editors
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1 expression may be a biomarker of local failure in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma following radiotherapy, according to research published in Clinical Cancer Research...
PD-L1...
05/16/2017
Journal of Clinical Pathways
Research Reports
05/12/2017
Whitney C Rhodes, PhD, MSPA
Yvonne Kellar-Guenther, PhD
Arnold H Levinson, PhD, MJ
Andrea Dwyer, BS
R Mark Gritz, PhD
Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...
Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...
...
05/12/2017
Journal of Clinical Pathways
Department
03/15/2017
JCP Editors
Researchers debuted guidelines for a two-tiered cardiac monitoring system aimed at identifying cancer survivors considered at high risk for cardiotoxic events. ----- Related Content Prostate Cancer Treatment...
Researchers debuted guidelines for a two-tiered cardiac monitoring system aimed at identifying cancer survivors considered at high risk for cardiotoxic events. ----- Related Content Prostate Cancer Treatment...
...
03/15/2017
Journal of Clinical Pathways
Research in Review
03/07/2017
JCP Editors
Using body composition metrics to determine dosage of anthracyclines-taxane based chemotherapy for patients with breast cancer can reduce treatment-related toxicity, according to a study published in Clinical Cancer...
Using body composition metrics to determine dosage of anthracyclines-taxane based chemotherapy for patients with breast cancer can reduce treatment-related toxicity, according to a study published in Clinical Cancer...
Using...
03/07/2017
Journal of Clinical Pathways
Research in Review
02/13/2017
JCP Editors
The utilization of a novel preoperative frailty screening system reduced mortality up to 365 days postsurgery and may serve as an easily implementable tool for assessing older surgical patients, according to research...
The utilization of a novel preoperative frailty screening system reduced mortality up to 365 days postsurgery and may serve as an easily implementable tool for assessing older surgical patients, according to research...
The...
02/13/2017
Journal of Clinical Pathways
Research in Review
01/31/2017
JCP Editors
Patients with newly-diagnosed non-small cell lung cancer (NSCLC) who experience anxiety are at a higher risk of cancer-specific mortality, according to research published in the Journal of Pain and Symptom...
Patients with newly-diagnosed non-small cell lung cancer (NSCLC) who experience anxiety are at a higher risk of cancer-specific mortality, according to research published in the Journal of Pain and Symptom...
...
01/31/2017
Journal of Clinical Pathways